Affiliation:
1. Department of Biochemistry and Microbiology, University of Zululand, KwaDlangezwa 3886, South Africa
2. Department of Biochemistry, North-West University, Mafikeng 2745, South Africa
3. Biomedical Research and Innovation Platform and South African Medical Research Council, Cape Town 7505, South Africa
Abstract
A newfound appreciation for the benefits of herbal treatments has emerged in recent decades. However, herbal medication production still needs to establish standardized protocols that adhere to strict guidelines for quality assurance and risk minimization. Although the therapeutic effects of herbal medicines are extensive, the risk of herb–drug interactions remains a serious concern, limiting their use. Therefore, a robust, well-established liver model that can fully represent the liver tissue is required to study potential herb–drug interactions to ensure herbal medicines’ safe and effective use. In light of this, this mini review investigates the existing in vitro liver models applicable to detecting herbal medicines’ toxicity and other pharmacological targets. This article analyzes the benefits and drawbacks of existing in vitro liver cell models. To maintain relevance and effectively express the offered research, a systematic strategy was employed to search for and include all discussed studies. In brief, from 1985 to December 2022, the phrases “liver models”, “herb–drug interaction”, “herbal medicine”, “cytochrome P450”, “drug transporters pharmacokinetics”, and “pharmacodynamics” were combined to search the electronic databases PubMed, ScienceDirect, and the Cochrane Library.
Funder
South African Medical Research Council
Subject
Drug Discovery,Pharmaceutical Science,Molecular Medicine
Reference42 articles.
1. Trends in use, pharmacology, and clinical applications of emerging herbal nutraceuticals;Williamson;Br. J. Pharmacol.,2020
2. Acedhars Unilag COVID-19 Response Team, Akindele, A.J., Agunbiade, F.O., Sofidiya, M.O., Awodele, O., Sowemimo, A., Ade-Ademilua, O., Akinleye, M.O., Ishola, I.O., and Orabueze, I. (2020). COVID-19 pandemic: A case for phytomedicines. Nat. Prod. Commun., 15, 1934578X20945086.
3. Use of herbal drugs to treat COVID-19 should be with caution;Yang;Lancet,2020
4. Incidence of adverse drug reactions in hospitalized patients: A meta-analysis of prospective studies;Lazarou;J. Am. Med. Assoc.,1998
5. Herbal and dietary supplement–drug interactions: A systematic review and meta-analysis;Gardiner;J. Clin. Pharmacol.,2008